The Latin America Office works to ensure that the range of FDA-regulated products that are exported to the United States from this region meet FDA requirements. This includes products that are developed, tested, manufactured, grown and/or processed in Mexico, Bermuda, the Bahamas and all countries and territories in Central America, South America, and the Caribbean. The Latin America Office also facilitates FDA’s bilateral and multilateral collaborative efforts in the region.
Medical devices and foods comprise most exports to the United States from the Latin America region. Almost all the products exported to the United States from the region come from 12 countries: Mexico, Dominican Republic, Chile, Costa Rica, Guatemala, Colombia, Honduras, Ecuador, Peru, Brazil, Argentina, and El Salvador. In addition, although not among the top exporters to the United States, Nicaragua and Panama are important sources of certain high-risk commodities such as seafood.
FDA offices in Latin America include a headquarters post in San Jose, Costa Rica, and posts in Santiago, Chile and Mexico City, Mexico.
Focus on Latin America
Safety of Drug Residues in Animals Destined for Human Consumption FDA Team Expert in Norovirus Supports the ISP with Methodologies for the Detection of the Virus FDA Expands Presence Outside U.S. with Opening of Mexico City Post HHS-FDA Launches first-event Workshop on Good Clinical Practices in the Americas